As the clinical landscape for GLP-1s continues to evolve, were committed to supporting plan sponsors with evidence-based, clinically appropriate coverage, cost, and care solutions that can help control spend without compromising health outcomes.
The results were striking: participants on oral semaglutide achieved a mean weight loss of 13.6%, compared to just 2.2% on placebo
But, Shin said, if insurance stops covering the medications for nondiabetic patients, they may delay treatments for obesity and develop Type 2 diabetes after all
No brand name has been approved or officially assigned
Potency may differ from labeled amounts
If youve been vomiting for more than a few weeks, its worth giving us a call